F.L. Putnam Investment Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $20.2M | Buy |
57,303
+2,010
| +4% | +$717K | 0.3% | 64 |
|
|
2025
Q4 | $18.1M | Buy |
55,293
+1,169
| +2% | +$371K | 0.26% | 69 |
|
|
2025
Q3 | $15.3M | Buy |
54,124
+1,044
| +2% | +$303K | 0.23% | 82 |
|
|
2025
Q2 | $14.8M | Sell |
53,080
-3,625
| -6% | -$1.03M | 0.25% | 83 |
|
|
2025
Q1 | $17.7M | Sell |
56,705
-1,621
| -3% | -$479K | 0.33% | 66 |
|
|
2024
Q4 | $15.2M | Sell |
58,326
-14,869
| -20% | -$4.41M | 0.28% | 72 |
|
|
2024
Q3 | $21.8M | Buy |
73,195
+2,133
| +3% | +$698K | 0.39% | 52 |
|
|
2024
Q2 | $22.2M | Buy |
71,062
+16,386
| +30% | +$4.81M | 0.42% | 54 |
|
|
2024
Q1 | $15.5M | Buy |
54,676
+972
| +2% | +$284K | 0.33% | 67 |
|
|
2023
Q4 | $15.5M | Buy |
53,704
+397
| +0.7% | +$108K | 0.36% | 63 |
|
|
2023
Q3 | $14.3M | Buy |
53,307
+1,791
| +3% | +$447K | 0.4% | 57 |
|
|
2023
Q2 | $11.4M | Buy |
51,516
+1,055
| +2% | +$245K | 0.31% | 75 |
|
|
2023
Q1 | $12.2M | Sell |
50,461
-722
| -1% | -$177K | 0.4% | 60 |
|
|
2022
Q4 | $13.4M | Sell |
51,183
-104
| -0.2% | -$27.9K | 0.49% | 52 |
|
|
2022
Q3 | $11.6M | Sell |
51,287
-203
| -0.4% | -$49.2K | 0.45% | 48 |
|
|
2022
Q2 | $12.5M | Buy |
51,490
+3,458
| +7% | +$847K | 0.46% | 53 |
|
|
2022
Q1 | $11.6M | Sell |
48,032
-878
| -2% | -$202K | 0.37% | 61 |
|
|
2021
Q4 | $11M | Sell |
48,910
-882
| -2% | -$186K | 0.34% | 64 |
|
|
2021
Q3 | $10.6M | Sell |
49,792
-10,925
| -18% | -$2.51M | 0.36% | 66 |
|
|
2021
Q2 | $14.8M | Buy |
60,717
+764
| +1% | +$188K | 0.51% | 52 |
|
|
2021
Q1 | $14.9M | Sell |
59,953
-5,187
| -8% | -$1.24M | 0.65% | 43 |
|
|
2020
Q4 | $15M | Sell |
65,140
-15,904
| -20% | -$3.67M | 0.7% | 41 |
|
|
2020
Q3 | $20.6M | Buy |
81,044
+2,095
| +3% | +$519K | 1.13% | 25 |
|
|
2020
Q2 | $18.6M | Buy |
78,949
+17,311
| +28% | +$3.95M | 1.11% | 25 |
|
|
2020
Q1 | $12.5M | Buy |
61,638
+5,878
| +11% | +$1.28M | 0.95% | 29 |
|
|
2019
Q4 | $13.4M | Buy |
55,760
+8,401
| +18% | +$1.85M | 0.83% | 33 |
|
|
2019
Q3 | $9.16M | Sell |
47,359
-2,107
| -4% | -$404K | 0.65% | 52 |
|
|
2019
Q2 | $9.12M | Sell |
49,466
-3,907
| -7% | -$700K | 0.73% | 44 |
|
|
2019
Q1 | $10.1M | Buy |
53,373
+2,810
| +6% | +$537K | 0.85% | 36 |
|
|
2018
Q4 | $9.84M | Buy |
50,563
+29,779
| +143% | +$5.81M | 1.07% | 30 |
|
|
2018
Q3 | $4.31M | Buy |
20,784
+17,482
| +529% | +$3.45M | 0.39% | 70 |
|
|
2018
Q2 | $610K | Sell |
3,302
-15,471
| -82% | -$2.74M | 0.06% | 155 |
|
|
2018
Q1 | $3.2M | Buy |
18,773
+7,286
| +63% | +$1.34M | 0.29% | 93 |
|
|
2017
Q4 | $2M | Buy |
11,487
+9,090
| +379% | +$1.61M | 0.18% | 110 |
|
|
2017
Q3 | $447K | Buy |
+2,397
| New | +$425K | 0.04% | 179 |
|
|
2017
Q1 | $328K | Sell |
1,999
-398
| -17% | -$66.1K | 0.03% | 187 |
|
|
2016
Q4 | $350K | Sell |
2,397
-1,588
| -40% | -$239K | 0.04% | 168 |
|
|
2016
Q3 | $665K | Buy |
+3,985
| New | +$674K | 0.08% | 130 |
|
Other funds holding AMGN
VCM
VPM
F.L. Putnam Investment Management's AMGN Position: Q1 2026 in Review
F.L. Putnam Investment Management increased its Amgen (AMGN) stake by 3.6% in Q1 2026, buying an estimated $717K and bringing the position to 57,303 shares worth $20.2M. The position accounts for 0.3% of the portfolio, ranked #64.
F.L. Putnam Investment Management first reported a position in AMGN in Q3 2016 and has held it in 38 quarters since. The position peaked at $22.2M in Q2 2024. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- F.L. Putnam Investment Management held 57,303 shares of Amgen worth $20.2M as of Q1 2026.
- F.L. Putnam Investment Management bought 2,010 Amgen shares in Q1 2026, an estimated $717K.
- Amgen made up 0.3% of F.L. Putnam Investment Management's portfolio in Q1 2026, its #64 holding.
- F.L. Putnam Investment Management first reported a position in Amgen in Q3 2016 and has held it in 38 quarters since.
- F.L. Putnam Investment Management's Amgen position peaked at $22.2M in Q2 2024.
- 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on F.L. Putnam Investment Management's 13F filing for Q1 2026, filed 5 May 2026.